Diabetes Management is of utmost importance and we at Eris have been successful torch bearers in this regard.
In this journey, we have been determined to empower every diabetic patient with the best therapy optimization and we are extremely delighted to introduce you to our initiative “Gluxit Assure Programme”.
About Gluxit Assure Programme:
The power of generic Dapagliflozin has been helping all diabetics achieve better glucose control & improved cardio-renal outcomes since a year and a half. It is now time to revolutionize the treatment of T2DM’s in India. It is time to launch a programme specially crafted for all diabetic patients, providing stronger assurance with Dapagliflozin treatment and addressing all barriers and limitations.
We are delighted to initiate our ‘Gluxit Assure Programme’ through you and empower you to be a part of this journey to fight Diabetes.
Aim of Gluxit Assure Programme:
Address Treatment Inequality – We see significant gaps and inconsistencies among treated diabetic patients who are able to benefit from Dapagliflozin treatment, thereby indicating multiple unaddressed challenges across the therapy line. Our aim is to provide Dapagliflozin treatment to every diabetes patient and reduce the extent of treatment inequality.